PCD Franchise for Anti-Infectives — 50+ WHO-GMP Formulations
Comprehensive PCD franchise opportunity across the complete anti-infective spectrum. Carbapenems, cephalosporins, glycopeptides, aminoglycosides, polymyxins, macrolides, and tetracyclines — covering hospital-grade injectables and outpatient oral preparations.
Submit Anti-Infectives Franchise Application WhatsApp Enquiry
A Focused Anti-Infectives PCD Franchise Opportunity
Anti-infectives constitute the largest pharmaceutical therapeutic category in India by both prescription volume and revenue. Hospital antibiotic resistance management, outpatient infection treatment, and surgical prophylaxis sustain consistent demand. BIOFRIL HEALTHCARE’s anti-infective division spans the complete formulation hierarchy from first-line oral antibiotics to reserve carbapenems for multi-drug-resistant infections.
- 50+ Anti-Infectives formulations across the relevant therapeutic and dosage form spectrum
- WHO-GMP certified manufacturing with Certificate of Analysis issued with every batch
- Monopoly district allocation documented in franchise agreement
- Suitable for franchise partners with hospital procurement networks, ICU pharmacy supply contracts, or established general practitioner prescriber bases
- Comprehensive promotional support: visual aids, Medical Representative kits, doctor sample packs, scientific literature
- Hospital and institutional tender documentation prepared in advance
Anti-Infectives Product Categories
- Carbapenems: Meropenem (FARAMERO-250/500/1000), Imipenem-Cilastatin (IMIFRIL-CI)
- Cephalosporins: Cefepime (FRILOPIME), Cefoperazone-Sulbactam (CEF-ZONERA-S), Ceftriaxone (RILCEFTA series), Cefuroxime (CEFUROME)
- Glycopeptides: Vancomycin (TEVANAN-500/1000), Teicoplanin (TECATRON-200/400)
- Penicillin combinations: Piperacillin-Tazobactam (PIPFRIL-TZ-4500), Amoxicillin-Clavulanate (TEXAMOXY-CV)
- Aminoglycosides: Amikacin (FRILKACIN-250/500)
- Polymyxins: Colistimethate Sodium (ZUCOLI-1MIU/2MIU)
- Macrolides: Azithromycin (VOAZIIX-500), Clarithromycin (CARFRILL-500)
- Lincosamides: Clindamycin (VEMCLIEX-300/600)
- Tetracyclines: Doxycycline (VEMDOXEX), Tigecycline (BF DETIGIN)
- Oxazolidinones: Linezolid (LINFRIL)
- Antivirals: Acyclovir (CYCOZAB)
Five-Step Onboarding
- Step 1 — Enquiry: Communicate target district and prescriber base profile
- Step 2 — Commercial Proposal & Agreement: Receive net pricing schedules and execute the monopoly franchise agreement
- Step 3 — Initial Order: Configure across the 50+ Stock Keeping Unit portfolio
- Step 4 — Promotional Kit Dispatch: Receive samples, literature, and visual aids
- Step 5 — Market Activation: Commence suitable outreach with structured business development support
Submit Anti-Infectives Franchise Application
Territories available across India. Monopoly district allocation. Submit your application today.
FAQs — PCD Franchise for Anti-Infectives
What is BIOFRIL HEALTHCARE’s minimum order quantity for PCD franchise?
Minimum order quantity varies by division and product category. Critical Care injectables typically start at 50 units per SKU; general range tablets/capsules from 100 strips per SKU. Our business development team confirms specific MOQ in the commercial proposal.
Does BIOFRIL HEALTHCARE provide monopoly district allocation for PCD franchise partners?
Yes. All PCD franchise agreements document monopoly territorial allocation at district level. Once a district is allocated to a franchise partner, BIOFRIL HEALTHCARE will not appoint another PCD partner in the same district for the duration of the agreement.
What promotional support does BIOFRIL HEALTHCARE provide to PCD franchise partners?
The promotional kit includes visual aids, Medical Representative kits, doctor sample packs, scientific literature, pricing schedules, and product brochures. Marketing materials are dispatched along with the inaugural franchise order.
What are the payment terms for the inaugural PCD franchise order?
Standard payment terms are 50% advance with the purchase order and the remaining 50% prior to dispatch. Subsequent replenishment orders may be eligible for revised terms based on commercial track record.
Which certifications does BIOFRIL HEALTHCARE hold?
BIOFRIL HEALTHCARE holds WHO-GMP, ISO 9001:2015, FSSAI Central License (No. 13026999000031), HACCP, and AYUSH manufacturing licenses. Drug License: WLF21B2026CH000085 (valid through March 2031). All certifications available for review during partnership due diligence.
How does BIOFRIL HEALTHCARE handle hospital tender supply documentation?
Hospital and institutional tender documentation including Certificates of Analysis, WHO-GMP certificates, ISO certificates, stability data, and regulatory dossiers is prepared in advance and provided to franchise partners on request for tender submission support.
Explore Other Therapeutic Categories
Anti-Infectives →
Carbapenems, cephalosporins, glycopeptides, aminoglycosides.
Cardiac & Diabetic →
Antihypertensives, statins, antidiabetics, cardiovascular preparations.
Paediatric →
Antibiotic dry syrups, antipyretic preparations, paediatric multivitamins.
Dermatology →
Topical antifungals, antibacterials, corticosteroids, acne preparations.
Gynaecology →
Prenatal, iron-folic, hormone therapy, women\’s wellness formulations.
Critical Care Division →
Complete 273+ injectable portfolio for hospital tender supply.